A recent study indicates that individuals who discontinue blockbuster GLP-1 drugs like Wegovy and Mounjaro may regain shed pounds far faster than those who stop conventional diet and exercise plans.
Published data in a prominent health publication shows that while obese individuals often shed a large proportion of their total mass while undergoing treatment, the mass returns at an estimated rate of 0.8 kg per month after stopping.
"Users purchasing these treatments must be aware of the potential of fast rebound weight gain when the treatment is stopped," warns expert Dr. Susan Jebb.
This pace of regain implies a reversion to original mass in about a year and a half.
Analyzing Approaches
The analysis, which reviewed dozens of trials involving thousands of patients, compared the effects of GLP-1 agonists with conventional dieting.
Scientists emphasize that individuals who lose weight through dieting usually have a more gradual creep back—around 100 grams monthly—post-intervention.
Understanding the Quick Rebound
Nutrition scientists believe the way of the drugs explains the accelerated regain.
The injections copy a natural hormone called glucagon-like peptide-1, which controls appetite.
"Artificially providing the hormone levels several times higher than normal may cause the body to generate a reduced amount of its own natural GLP-1, and could reduce sensitivity to its effects," explained Dr. Adam Collins, a nutrition researcher.
"Stopping of this hormone supplement leads to appetite is uncontrolled, making excessive eating a significant risk."
A Chronic Issue?
The NHS advise the injections for individuals with obesity-related medical conditions, accompanied by prescribed diet and exercise modifications.
Professionals contend that, given the significant potential of weight regain, the treatment is often ongoing.
This perspective is echoed by drug manufacturers, who say that the findings "emphasize the long-term nature of obesity," comparing it to managing conditions like diabetes.
Patient Accounts
Individuals who have discontinued the medication report a powerful return of cravings.
"It felt as if something that goes on and you're instantly extremely hungry," said one woman.
The struggle is exacerbated if users have not adopted permanent lifestyle or habit modifications during therapy.
Growing Interest
Survey data indicate that millions of people in the UK have used weight-loss jabs in the last 12 months, with interest continuing to grow.
- Use is greater among women compared to males.
- The middle-aged demographic shows the highest level of interest.
- Many obtain the drugs through private healthcare rather than public health services.
Finally, experts stress that while GLP-1 drugs are potent agents for weight loss, they are not a permanent fix and long-term success hinges on integrated lifestyle changes.
